These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17011846)

  • 21. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
    Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
    Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
    Alvarado-Castillo B; Santa Cruz-Pavlovich FJ; Gonzalez-Castillo C; Vidal-Paredes IA; Garcia-Benavides L; Rosales-Gradilla ME; Navarro-Partida J
    BMC Ophthalmol; 2023 Jul; 23(1):335. PubMed ID: 37501105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions.
    Kaliki S; Sharma A; Vempuluru VS
    Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
    Singh M; Gautam N; Kaur M
    Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
    Skippen B; Tsang HH; Assaad NN; Coroneo MT
    Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.
    Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME
    Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
    Kim BH; Kim MK; Wee WR; Oh JY
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia].
    Toledano Fernández N; García Sáenz S; Díaz Valle D; Arteaga Sánchez A; Segura Bedmar M; Lorenzo Giménez S; Cortés Lambea L
    Arch Soc Esp Oftalmol; 2003 May; 78(5):265-71. PubMed ID: 12789630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Apr; 110(4):625-6; author reply 626. PubMed ID: 12689863
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Jun; 110(6):1262-3; author reply 1263. PubMed ID: 12799258
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.